Steve666

Biogen (BIIB) A Roadmap...

ロング
Steve666 アップデート済   
NASDAQ:BIIB   Biogen Inc.
BIIB came out a nice Gartley Pattern on 4/22.

First stop should be the $277 area as AB=CD, where I would think there will be some profit taking.

Upside targets ($290+) are shown as this evolves into a possible Deep Crab Harmonic Pattern.

Biogen needs FDA drug approval, descent earning against healthy market backdrop for this to happen.


In higher time-frames you may also have a cup and handle formation.

As usual do your own DD

S.
コメント:
An update...
コメント:
Biogen rallied to our $277+ level and backed off as expected.

It would not surprise me to see some consolidation here and then and run up to the upper D level provided we remain in a healthy broad market

コメント:
Acting quite well..

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。